TipRanks
Advertisement
Advertisement
Fresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
PremiumRatingsFresenius Medical Care: Sell Rating Reiterated as Growth Concerns Persist and $32 Price Target Remains Unchanged
2M ago
0H9X Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0H9X Earnings this Week: How Will it Perform?
2M ago
Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas
Premium
The Fly
Fresenius Medical downgraded to Underperform from Neutral at BNP Paribas
2M ago
PremiumRatingsSell Rating Reaffirmed on Limited Earnings Visibility and Competitive Pressures; €32 Price Target Maintained
3M ago
Fresenius Medical launches first tranche of share buyback program
Premium
The Fly
Fresenius Medical launches first tranche of share buyback program
4M ago
Fresenius Medical announces EUR 1B share buyback program
Premium
The Fly
Fresenius Medical announces EUR 1B share buyback program
4M ago
Fresenius Medical reports Q1 EPS ex-items EUR0.91 vs. EUR0.84 last year
PremiumThe FlyFresenius Medical reports Q1 EPS ex-items EUR0.91 vs. EUR0.84 last year
5M ago
Fresenius Medical sees FY26 revenue EUR19.628B
Premium
The Fly
Fresenius Medical sees FY26 revenue EUR19.628B
5M ago
Premium
Ratings
Fresenius Medical Care: Weaker Growth, Limited Margin Visibility Keep Underperform Rating as €32 Price Target Reaffirmed
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―